The pharmacology and clinical evaluation of aprindine a new antiarrhythmic agent.
D000284:Administration, Oral; D000368:Aged; D000814:Aniline Compounds; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001646:Bile / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D005117:Cardiac Complexes, Premature / Q000188:drug therapy; D002302:Cardiac Output / Q000187:drug effects; D003864:Depression, Chemical; D004048:Diethylamines; D006207:Half-Life; D006352:Heart Ventricles; D006801:Humans; D007189:Indans / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use* / Q000652:urine; D007192:Indenes / Q000627:therapeutic use*; D007275:Injections, Intravenous; D008875:Middle Aged; D011674:Pulse / Q000187:drug effects; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy; D014927:Wolff-Parkinson-White Syndrome / Q000188:drug therapy
D000814:Aniline Compounds; D000889:Anti-Arrhythmia Agents; D004048:Diethylamines; D007189:Indans; D007192:Indenes